DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.98
Delayed Data
As of May 22
 -0.0025 / -0.25%
Today’s Change
0.78
Today|||52-Week Range
2.84
-10.09%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zarrabian Saiid
Interim Chief Executive Officer
Buy11/14/201755,000$0.82$45.1K+17.08%
Bacha Jeffrey A
Chief Executive Officer
Buy6/26/20176,700$3.60$24.1K-55.05%
Bell John K
Director
Buy6/06/201710,000$2.12$21.2K-51.96%
Praill Scott
Chief Financial Officer
Buy6/06/20179,500$2.10$20.0K-51.96%
Bell John K
Director
Buy6/26/20174,167$3.60$15.0K-55.05%
Mohr Erich
Director
Buy6/26/20174,167$3.60$15.0K-55.05%
Praill Scott
Chief Financial Officer
Buy6/26/20174,167$3.60$15.0K-55.05%
Praill Scott
Chief Financial Officer
Buy10/05/201717,500$0.85$14.9K+11.36%
Bell John K
Director
Buy11/16/201718,129$0.81$14.7K+22.35%
Bacha Jeffrey A
Chief Executive Officer
Buy6/06/20175,000$2.12$10.6K-51.96%
Page of 2